Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, England, UK.
CBM S.c.r.l., 34012 Trieste, Italy.
J Exp Med. 2014 Dec 15;211(13):2617-33. doi: 10.1084/jem.20140317. Epub 2014 Dec 1.
The Polycomb group (PcG) protein Bmi1 is an essential epigenetic regulator of stem cell function during normal development and in adult organ systems. We show that mild up-regulation of Bmi1 expression in the adult stem cells of the skeletal muscle leads to a remarkable improvement of muscle function in a mouse model of Duchenne muscular dystrophy. The molecular mechanism underlying enhanced physiological function of Bmi1 depends on the injury context and it is mediated by metallothionein 1 (MT1)-driven modulation of resistance to oxidative stress in the satellite cell population. These results lay the basis for developing Bmi1 pharmacological activators, which either alone or in combination with MT1 agonists could be a powerful novel therapeutic approach to improve regeneration in muscle wasting conditions.
多梳抑制复合物(PcG)蛋白 Bmi1 是正常发育和成年器官系统中干细胞功能的重要表观遗传调节剂。我们发现,在 Duchenne 肌营养不良症的小鼠模型中,轻度上调骨骼肌中的 Bmi1 表达可显著改善肌肉功能。Bmi1 表达增强的生理功能的分子机制取决于损伤背景,并通过金属硫蛋白 1(MT1)驱动的卫星细胞群抵抗氧化应激的调节来介导。这些结果为开发 Bmi1 药理学激活剂奠定了基础,这些激活剂单独或与 MT1 激动剂联合使用可能是改善肌肉消耗条件下再生的一种强大的新型治疗方法。